ZYLET: payments to doctors
Payments that named ZYLET as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $236K
- Providers
- 4,470
- Transactions
- 10,439
- Average per transaction
- $23
The per-transaction average — $23 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,470 providers the average total is $53, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $177,294 | 75.1% |
| Bausch & Lomb Americas Inc. | $58,673 | 24.9% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $22 | 0.0% |